QQQ   390.19 (+0.26%)
AAPL   190.40 (+0.32%)
MSFT   382.70 (+1.08%)
META   338.99 (+1.28%)
GOOGL   137.20 (+0.58%)
AMZN   147.03 (-0.47%)
TSLA   246.72 (+4.51%)
NVDA   478.21 (-0.87%)
NIO   7.21 (+0.28%)
BABA   76.72 (-1.04%)
AMD   122.01 (-0.52%)
T   16.18 (-0.19%)
F   10.39 (+0.48%)
MU   76.12 (-1.79%)
CGC   0.54 (-1.82%)
GE   118.85 (-0.93%)
DIS   92.50 (-2.81%)
AMC   6.70 (-1.47%)
PFE   29.69 (-1.49%)
PYPL   58.47 (+3.69%)
XOM   103.90 (-0.06%)
QQQ   390.19 (+0.26%)
AAPL   190.40 (+0.32%)
MSFT   382.70 (+1.08%)
META   338.99 (+1.28%)
GOOGL   137.20 (+0.58%)
AMZN   147.03 (-0.47%)
TSLA   246.72 (+4.51%)
NVDA   478.21 (-0.87%)
NIO   7.21 (+0.28%)
BABA   76.72 (-1.04%)
AMD   122.01 (-0.52%)
T   16.18 (-0.19%)
F   10.39 (+0.48%)
MU   76.12 (-1.79%)
CGC   0.54 (-1.82%)
GE   118.85 (-0.93%)
DIS   92.50 (-2.81%)
AMC   6.70 (-1.47%)
PFE   29.69 (-1.49%)
PYPL   58.47 (+3.69%)
XOM   103.90 (-0.06%)
QQQ   390.19 (+0.26%)
AAPL   190.40 (+0.32%)
MSFT   382.70 (+1.08%)
META   338.99 (+1.28%)
GOOGL   137.20 (+0.58%)
AMZN   147.03 (-0.47%)
TSLA   246.72 (+4.51%)
NVDA   478.21 (-0.87%)
NIO   7.21 (+0.28%)
BABA   76.72 (-1.04%)
AMD   122.01 (-0.52%)
T   16.18 (-0.19%)
F   10.39 (+0.48%)
MU   76.12 (-1.79%)
CGC   0.54 (-1.82%)
GE   118.85 (-0.93%)
DIS   92.50 (-2.81%)
AMC   6.70 (-1.47%)
PFE   29.69 (-1.49%)
PYPL   58.47 (+3.69%)
XOM   103.90 (-0.06%)
QQQ   390.19 (+0.26%)
AAPL   190.40 (+0.32%)
MSFT   382.70 (+1.08%)
META   338.99 (+1.28%)
GOOGL   137.20 (+0.58%)
AMZN   147.03 (-0.47%)
TSLA   246.72 (+4.51%)
NVDA   478.21 (-0.87%)
NIO   7.21 (+0.28%)
BABA   76.72 (-1.04%)
AMD   122.01 (-0.52%)
T   16.18 (-0.19%)
F   10.39 (+0.48%)
MU   76.12 (-1.79%)
CGC   0.54 (-1.82%)
GE   118.85 (-0.93%)
DIS   92.50 (-2.81%)
AMC   6.70 (-1.47%)
PFE   29.69 (-1.49%)
PYPL   58.47 (+3.69%)
XOM   103.90 (-0.06%)

Merrimack Pharmaceuticals (MACK) News Today

$12.78
-0.12 (-0.93%)
(As of 11/28/2023 ET)
Compare
Today's Range
$12.76
▼
$12.92
50-Day Range
$12.02
▼
$12.90
52-Week Range
$10.10
▼
$13.15
Volume
14,819 shs
Average Volume
87,953 shs
Market Capitalization
$183.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media
SourceHeadline
morningstar.com logoMerrimack Pharmaceuticals Inc MACK
morningstar.com - November 10 at 11:39 PM
finance.yahoo.com logoMerrimack Reports Third Quarter 2023 Financial Results
finance.yahoo.com - November 2 at 7:27 PM
stockhouse.com logoOnconova Expands Leadership Team with Two Key Appointments
stockhouse.com - October 24 at 8:53 AM
theglobeandmail.com logoThe Fight Against Pancreatic Cancer Just Gained a New Ally with $200M VC Firm
theglobeandmail.com - October 20 at 12:43 PM
finance.yahoo.com logoWestern Standard LLC Boosts Stake in Merrimack Pharmaceuticals Inc
finance.yahoo.com - August 15 at 3:36 PM
insidermonkey.com logoOnconova Therapeutics, Inc. (NASDAQ:ONTX) Q2 2023 Earnings Call Transcript
insidermonkey.com - August 13 at 8:09 AM
finance.yahoo.com logoMerrimack Reports Second Quarter 2023 Financial Results
finance.yahoo.com - August 3 at 8:17 PM
finanznachrichten.de logoPharming Group N.V.: Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board
finanznachrichten.de - July 18 at 1:19 AM
finance.yahoo.com logoPharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board
finance.yahoo.com - July 18 at 1:19 AM
marketbeat.com logoMerrimack Pharmaceuticals (NASDAQ:MACK) Stock Rating Lowered by StockNews.com
marketbeat.com - July 7 at 10:15 PM
marketbeat.com logoMerrimack Pharmaceuticals (NASDAQ:MACK) Downgraded to "Sell" at StockNews.com
marketbeat.com - June 23 at 10:15 PM
marketbeat.com logoMerrimack Pharmaceuticals, Inc. (NASDAQ:MACK) is 22Nw LP's 6th Largest Position
marketbeat.com - May 26 at 2:28 PM
marketbeat.com logoShort Interest in Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Increases By 6.7%
marketbeat.com - May 2 at 3:48 AM
marketbeat.com logoMerrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Sees Large Drop in Short Interest
marketbeat.com - April 21 at 7:54 AM
finance.yahoo.com logoRetail investors account for 38% of Merrimack Pharmaceuticals, Inc.'s (NASDAQ:MACK) ownership, while hedge funds account for 33%
finance.yahoo.com - April 19 at 7:33 AM
marketwatch.com logoGlobal Receptor Tyrosine Protein Kinase ERBB 3 Market Size Emerging Trends and Will Generate New Growth Opportunities Status 2030 By VMReports
marketwatch.com - April 16 at 12:29 AM
usnews.com logoMerrimack Valley High School
usnews.com - April 15 at 7:26 PM
thestreet.com logoWhy Merrimack Pharmaceuticals (MACK) Stock is Down in After-Hours Trading Today
thestreet.com - April 3 at 8:58 AM
nytimes.com logoTrack Covid-19 in Merrimack County, New Hampshire
nytimes.com - March 30 at 11:21 PM
marketwatch.com logoOncology Injection Drug Market Size and Forecast till 2031
marketwatch.com - March 22 at 3:10 PM
msn.com logoWhy Jounce Therapeutics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
msn.com - March 15 at 12:41 PM
nytimes.com logoMerrimack Won a Title, but the N.C.A.A. Tournament Will Have to Wait
nytimes.com - March 10 at 11:49 PM
msn.com logoHistogen GAAP EPS of -$3.46, revenue of $3.77M misses by $0.35M
msn.com - March 9 at 10:07 PM
finance.yahoo.com logoMerrimack Reports Full Year 2022 Financial Results
finance.yahoo.com - March 9 at 5:06 PM
yahoo.com logoMerrimack, United States - Weather Forecasts | Maps | News - Yahoo Weather
yahoo.com - March 7 at 5:40 PM
uk.finance.yahoo.com logoThe Global Liposomal Products Market is forecast to grow by $3,183.63 mn during 2022-2027, accelerating at a CAGR of 9.65% during the forecast period
uk.finance.yahoo.com - February 24 at 3:46 AM
finance.yahoo.com logoRadionetics Oncology Appoints Istvan Molnar, M.D. as Chief Medical Officer
finance.yahoo.com - February 22 at 10:25 AM
marketwatch.com logoGlobal HER2-Positive Breast Cancer Market to by In-depth Analysis of Revenue Forecast and Competitive Landscape 2030 By VMReports
marketwatch.com - February 19 at 6:06 PM
marketbeat.com logoInsider Buying: Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Director Buys 4,156 Shares of Stock
marketbeat.com - January 9 at 6:31 PM
marketbeat.com logoShort Interest in Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Decreases By 23.1%
marketbeat.com - January 2 at 12:09 PM
marketbeat.com logoTraders Buy High Volume of Merrimack Pharmaceuticals Put Options (NASDAQ:MACK)
marketbeat.com - December 19 at 11:09 AM
finance.yahoo.com logoBullish Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) insiders filled their treasuries with US$574k worth of stock over last year
finance.yahoo.com - December 13 at 3:46 PM
marketbeat.com logoMerrimack Pharmaceuticals (NASDAQ:MACK) Research Coverage Started at StockNews.com
marketbeat.com - December 7 at 3:52 AM
finance.yahoo.com logoMerrimack Pharmaceuticals Extends Section 382 Net Operating Loss Rights Plan
finance.yahoo.com - December 5 at 4:13 PM
marketbeat.com logoMerrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Short Interest Up 226.0% in November
marketbeat.com - November 28 at 11:09 PM
marketbeat.com logoStockNews.com Begins Coverage on Merrimack Pharmaceuticals (NASDAQ:MACK)
marketbeat.com - November 22 at 5:12 AM
finance.yahoo.com logoBiotech Stock Roundup: MACK Up on Study Data, MRNA Offers Vaccine Update & More
finance.yahoo.com - November 16 at 4:52 PM
finance.yahoo.com logoHedge funds investors control 44% of Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) and were rewarded last week after stock increased 228%
finance.yahoo.com - November 10 at 6:47 PM
nasdaq.com logoMerrimack Soars On Promising Data From Ipsen's NAPOLI-3 Trial
nasdaq.com - November 9 at 2:01 PM
finance.yahoo.com logoMerrimack stock rockets 200% after positive trial data on Onivyde pancreatic cancer treatment
finance.yahoo.com - November 9 at 2:01 PM
marketbeat.com logoInvestors Purchase High Volume of Merrimack Pharmaceuticals Put Options (NASDAQ:MACK)
marketbeat.com - November 9 at 10:51 AM
investorplace.com logoWhy Is Merrimack Pharmaceuticals (MACK) Stock Up 220% Today?
investorplace.com - November 9 at 10:24 AM
marketwatch.com logoMerrimack Pharmaceuticals Shares Soar Premarket on Ipsen Study Success >MACK
marketwatch.com - November 9 at 9:01 AM
marketbeat.com logo
marketbeat.com - November 8 at 10:17 AM
finance.yahoo.com logoMerrimack Reports Third Quarter 2022 Financial Results
finance.yahoo.com - November 3 at 4:54 PM
seekingalpha.com logoReturn Of The Mack: A Deeply Misunderstood Near-Term Readout
seekingalpha.com - October 31 at 10:42 AM
marketwatch.com logoKnee Bursitis Treatment Market Analysis Research Report, Challenges, Scopes, Market Share, Revenue, and Forecasts 2022 to 2028
marketwatch.com - October 26 at 12:17 PM
usatoday.com logoMerrimack has 6 TDs in second half to run away from Wagner
usatoday.com - October 17 at 1:24 PM
fool.com logoMerrimack Pharmaceuticals (NASDAQ: MACK)
fool.com - September 2 at 10:45 PM
finance.yahoo.com logoCompanies Like Merrimack Pharmaceuticals (NASDAQ:MACK) Are In A Position To Invest In Growth
finance.yahoo.com - August 16 at 2:16 PM
Get Merrimack Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for MACK and its competitors with MarketBeat's FREE daily newsletter.



MACK Media Mentions By Week

MACK Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MACK
News Sentiment
▼
1.89

0.87
▲
Average
Medical
News Sentiment

MACK News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MACK Articles
This Week
▼
1

0
▲
MACK Articles
Average Week

Get Merrimack Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for MACK and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:MACK) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -